Epidemiological update: Polio in Israel, 14 October 2013
As of 3 October, wild-type poliovirus 1 (WPV1) was still being isolated in wastewater treatment plants across the country with some areas indicating an inconsistent or discontinued detection. However, no new sites in Israel with WPV1 in sewage were detected since the start of the bivalent oral polio vaccine (bOPV) immunisation campaign, according to personal communication from the Ministry of Health in Israel.
Epidemiological update: Suspected polio cases in Syria confirmed by WHO, 30 October 2013
Ten of the 22 acute flaccid paralysis (AFP) cases in the Syrian Arab Republic suspected of being caused by wild poliovirus have been confirmed as wild poliovirus type 1 (WPV1) by the World Health Organization (WHO).
Epidemiological update: A(H7N9) influenza virus, China, 19 December 2013
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) avian influenza virus in patients in eastern China.
Epidemiological update A(H7N9) influenza, 6 February 2014
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus in patients in eastern China. Since then, human cases have continued to be reported, and as of 7 February 2014 (Figure 1), there have been 308 laboratory-confirmed cases: Zhejiang (122), Guangdong (54), Shanghai (42), Jiangsu (36), Fujian (19), Hunan (7), Jiangxi (5), Henan (4), Anhui (4) ,Beijing (3), Shandong (2), Hebei (1), Guangxi (2), Guizhou (1), Hong Kong (4) and Taiwan (2). In addition, the virus has been detected in one asymptomatic case in Beijing.
Epidemiological update: MERS-CoV case imported to Turkey, 21 October 2014
On 18 October 2014, the Ministry of Health Turkey reported that a Turkish citizen working in Saudi Arabia died on 11 October 2014, ten days after onset of a confirmed MERS-CoV infection.
Epidemiological update: Human infection with avian influenza A(H7N9) virus, China
On 4 February 2015, the National Health and Family Planning Commission (NHFPC) of China notified WHO of 83 additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus. Onset dates ranged from 20 December 2014 to 27 January 2015.
Epidemiological update: Increase in travel-associated Legionnaires’ disease among EU travellers returning from Dubai in the last quarter of 2016
The ECDC ELDSNet surveillance scheme on travel-associated Legionnaires’ disease (TALD) observed an increase in the number of cases associated with travel to Dubai in the last quarter of 2016, compared with previous years.
Recent upsurge of A(H7N9) cases in China, updated rapid risk assessment
A steep increase of human cases of avian influenza A(H7N9) has been reported since the beginning of December 2016 from China. At present, the most immediate threat to EU citizens is to those living or visiting influenza A(H7N9)-affected areas in China concludes the updated rapid risk assessment.
Epidemiological update: Legionnaires’ disease cases associated with travel to Dubai, 8 March 2017
The ECDC surveillance scheme (ELDSNet) for travel-associated Legionnaires’ disease (TALD)  has observed an increase in the number of cases associated with travel to Dubai, United Arab Emirates (UAE) since the beginning of the last quarter of 2016 compared with the two previous years
Rapid risk assessment: Human fatality from highly pathogenic avian influenza A(H5N1) virus infection in Guangdong province, China
Following reports of a human fatality due to highly pathogenic avian influenza A(H5N1) virus infection in China’s Guangdong province, the European Commission requested an update to the assessment of risk of human-to-human transmission occurring. ECDC does not consider that there is any change to the previous assessments that the risk for EU/EEA countries is very low.